Baca; Manuel
Patent Applications and Registrations
Patent applications and USPTO patent grants for Baca; Manuel.The latest application filed is for "interleukin-2-fc fusion proteins and methods of use".
Company Profile
10.40.57
- Baca; Manuel - Lexington MA
- BACA; Manuel - Gaithersburg MD
- Baca; Manuel - Viewbank AU
- Baca; Manuel - Ivanhoe AU
- BACA; MANUEL - BLACK ROCK AU
- Baca; Manuel - Blackrock AU
- Baca; Manuel - East Gaithersburg MD
- Baca; Manuel - Villeurbanne FR
- Baca; Manuel - Victoria AU
- Baca; Manuel - Viewbark AU
- Baca; Manuel - Foster City CA
Patent Activity
| Patent | Date |
|---|---|
| INTERLEUKIN-2-Fc FUSION PROTEINS AND METHODS OF USE App 20220125884 - Baca; Manuel ; et al. | 2022-04-28 |
| Nucleic Acids Encoding A Tn3 Scaffold Comprising A Cd40l-specific Monomer Subunit App 20220089688 - COYLE; Anthony ; et al. | 2022-03-24 |
| FLT3L-Fc FUSION PROTEINS AND METHODS OF USE App 20220049021 - Ambrogelly; Alexandre ; et al. | 2022-02-17 |
| FLT3L-FC fusion proteins Grant 11,124,582 - Ambrogelly , et al. September 21, 2 | 2021-09-21 |
| CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOF App 20210260159 - BACA; MANUEL ; et al. | 2021-08-26 |
| Uricase sequences and methods of treatment Grant 11,098,289 - Baca , et al. August 24, 2 | 2021-08-24 |
| Uricase Sequences And Methods Of Treatment App 20210254024 - BACA; Manuel ; et al. | 2021-08-19 |
| CD40L-Fc fusion polypeptides and methods of use thereof Grant 10,975,155 - Baca , et al. April 13, 2 | 2021-04-13 |
| FLT3L-Fc FUSION PROTEINS AND METHODS OF USE App 20210070887 - Ambrogelly; Alexandre ; et al. | 2021-03-11 |
| FLT3L-Fc FUSION PROTEINS AND METHODS OF USE App 20210009718 - Ambrogelly; Alexandre ; et al. | 2021-01-14 |
| Antibodies Against G-csfr And Uses Thereof App 20210009701 - Nash; Andrew Donald ; et al. | 2021-01-14 |
| Uricase sequences and methods of treatment Grant 10,883,087 - Baca , et al. January 5, 2 | 2021-01-05 |
| Antibodies Against G-csfr And Uses Thereof App 20190055313 - Nash; Andrew Donald ; et al. | 2019-02-21 |
| Uricase Sequences And Methods Of Treatment App 20190048327 - BACA; Manuel ; et al. | 2019-02-14 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 10,106,617 - Nash , et al. October 23, 2 | 2018-10-23 |
| CD40L-specific TN3-derived scaffolds and methods of use thereof Grant 10,000,553 - Coyle , et al. June 19, 2 | 2018-06-19 |
| High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20170369579 - Nash; Andrew Donald ; et al. | 2017-12-28 |
| Anti-vegf Antibodies App 20170369564 - Baca; Manuel ; et al. | 2017-12-28 |
| CD40L-Fc Fusion Polypeptides And Methods Of Use Thereof App 20170327588 - Baca; Manuel ; et al. | 2017-11-16 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 9,777,062 - Nash , et al. October 3, 2 | 2017-10-03 |
| Antibodies Against G-csfr And Uses Thereof App 20170226214 - Nash; Andrew Donald ; et al. | 2017-08-10 |
| High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20160362497 - Nash; Andrew Donald ; et al. | 2016-12-15 |
| Anti-vegf Antibodies App 20160257738 - Baca; Manuel ; et al. | 2016-09-08 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 9,371,388 - Nash , et al. June 21, 2 | 2016-06-21 |
| Antibodies Against G-csfr And Uses Thereof App 20160031998 - Nash; Andrew Donald ; et al. | 2016-02-04 |
| TRAIL R2-specific multimeric scaffolds Grant 9,212,231 - Baca , et al. December 15, 2 | 2015-12-15 |
| Antibodies against G-CSFR and uses thereof Grant 9,193,793 - Nash , et al. November 24, 2 | 2015-11-24 |
| Protein scaffolds Grant 9,176,129 - Wu , et al. November 3, 2 | 2015-11-03 |
| Cd40l-specific Tn3-derived Scaffolds And Methods Of Use Thereof App 20150098955 - Coyle; Anthony ; et al. | 2015-04-09 |
| Anti-vegf Antibodies App 20150023951 - Baca; Manuel ; et al. | 2015-01-22 |
| Method Of Treating Cancer Comprising A Vegf-b Antagonist App 20140363445 - Nash; Andrew ; et al. | 2014-12-11 |
| Method of treating cancer comprising a VEGF-B antagonist Grant 8,822,644 - Nash , et al. September 2, 2 | 2014-09-02 |
| Protein Scaffolds App 20140141994 - Wu; Herren ; et al. | 2014-05-22 |
| High Affinity Antibody Antagonists Of Interleukin-13 Receptor Alpha 1 App 20140056915 - Nash; Andrew Donald ; et al. | 2014-02-27 |
| Protein scaffolds Grant 8,633,297 - Wu , et al. January 21, 2 | 2014-01-21 |
| Anti-IL-13R.alpha.1 antibodies and their uses thereof Grant 8,613,925 - Nash , et al. December 24, 2 | 2013-12-24 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 8,568,722 - Nash , et al. October 29, 2 | 2013-10-29 |
| IL-11 muteins Grant 8,540,977 - Baca September 24, 2 | 2013-09-24 |
| Trail R2-specific Multimeric Scaffolds App 20130096058 - Baca; Manuel ; et al. | 2013-04-18 |
| Fibronectin Type Iii Domain-based Multimeric Scaffolds App 20130079280 - Baca; Manuel ; et al. | 2013-03-28 |
| Anti-vegf Antibodies App 20130058927 - Baca; Manuel ; et al. | 2013-03-07 |
| Antibodies Against G-csfr And Uses Thereof App 20120321630 - NASH; Andrew Donald ; et al. | 2012-12-20 |
| Method of modulating cell survival and reagents useful for same Grant 8,299,027 - Bartlett , et al. October 30, 2 | 2012-10-30 |
| Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ralpha1) Grant 8,221,755 - Dunlop , et al. July 17, 2 | 2012-07-17 |
| Methods of treating inflammatory airway conditions by inhibition of IL-11 activity Grant 8,182,814 - Baca , et al. May 22, 2 | 2012-05-22 |
| Il-11 Muteins App 20110300100 - BACA; Manuel | 2011-12-08 |
| IL-11 muteins Grant 7,993,637 - Baca August 9, 2 | 2011-08-09 |
| Method Of Modulating Cell Survival And Reagents Useful For Same App 20110172143 - Bartlett; Perry Francis ; et al. | 2011-07-14 |
| Anti-vegf Antibodies App 20110081342 - BACA; MANUEL ; et al. | 2011-04-07 |
| Method of modulating cell survival and reagents useful for same Grant 7,919,471 - Bartlett , et al. April 5, 2 | 2011-04-05 |
| Anti-vegf Antibodies App 20110052575 - Baca; Manuel ; et al. | 2011-03-03 |
| Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof App 20110052597 - Nash; Andrew Donald ; et al. | 2011-03-03 |
| Monoclonal Antibody Against Interleukin-13 Receptor Alpha 1 (il-13ralpha1) App 20110020363 - DUNLOP; Felicity Meredith ; et al. | 2011-01-27 |
| Protein Scaffolds App 20100298541 - Wu; Herren ; et al. | 2010-11-25 |
| High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1 App 20100285035 - Nash; Andrew Donald ; et al. | 2010-11-11 |
| Monoclonal antibody against interleukin-13 receptor alpha 1 (IL-13Ra1) Grant 7,785,590 - Dunlop , et al. August 31, 2 | 2010-08-31 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 Grant 7,754,213 - Nash , et al. July 13, 2 | 2010-07-13 |
| Oxidation of propane to give acrylic acid using catalysts in a mixture of crystalline phases Grant 7,683,213 - Dubois , et al. March 23, 2 | 2010-03-23 |
| Treatment And Prophylaxis Of Th2 Mediated Disorders App 20090202533 - BACA; Manuel ; et al. | 2009-08-13 |
| Cytokine Muteins App 20090191148 - BACA; Manuel | 2009-07-30 |
| SOCS3 proteins Grant 7,517,959 - Norton , et al. April 14, 2 | 2009-04-14 |
| Method of Treating Cancer Comprising a Vegf-B Antgonist App 20080260729 - Nash; Andrew ; et al. | 2008-10-23 |
| Anti-vegf Antibodies App 20080226629 - Baca; Manuel ; et al. | 2008-09-18 |
| Anti-vegf Antibodies App 20080187534 - Baca; Manuel ; et al. | 2008-08-07 |
| High affinity antibody antagonists of interleukin-13 receptor alpha 1 App 20080166343 - Nash; Andrew Donald ; et al. | 2008-07-10 |
| Anti-VEGF antibodies Grant 7,375,193 - Baca , et al. May 20, 2 | 2008-05-20 |
| Anti-VEGF antibodies Grant 7,365,166 - Baca , et al. April 29, 2 | 2008-04-29 |
| Methods of regulating cytokine signalling App 20080057517 - Nicholson; Sandra Elaine ; et al. | 2008-03-06 |
| Anti-vegf antibodies Grant 7,297,334 - Baca , et al. November 20, 2 | 2007-11-20 |
| Anti-vegf Antibodies App 20070248610 - Baca; Manuel ; et al. | 2007-10-25 |
| Anti-vegf Antibodies App 20070196374 - Baca; Manuel ; et al. | 2007-08-23 |
| Methods of regulating cytokine signalling Grant 7,256,007 - Nicholson , et al. August 14, 2 | 2007-08-14 |
| Structure of SOCS and uses thereof App 20070179089 - Norton; Raymond Stanley ; et al. | 2007-08-02 |
| Anti-vegf Antibodies App 20070059302 - Baca; Manuel ; et al. | 2007-03-15 |
| Anti-vegf Antibodies App 20070059312 - Baca; Manuel ; et al. | 2007-03-15 |
| Anti-VEGF antibodies Grant 7,169,901 - Baca , et al. January 30, 2 | 2007-01-30 |
| Oxidation of propane to give acrylic acid using catalysts in a mixture of crystaline phases App 20060293538 - Dubois; Jean-Luc ; et al. | 2006-12-28 |
| SOCS-box containing peptides App 20060242718 - Willson; Tracy Ann ; et al. | 2006-10-26 |
| Screening methods using SOCS box-containing peptides Grant 7,078,174 - Willson , et al. July 18, 2 | 2006-07-18 |
| Anti-VEGF antibodies Grant 7,060,269 - Baca , et al. June 13, 2 | 2006-06-13 |
| Anti-VEGF antibodies App 20050112126 - Baca, Manuel ; et al. | 2005-05-26 |
| Method of modulating cell survival and reagents useful for same App 20050090442 - Bartlett, Perry Francis ; et al. | 2005-04-28 |
| Anti-VEGF antibodies Grant 6,884,879 - Baca , et al. April 26, 2 | 2005-04-26 |
| Monoclonal antibody against Interleukin-13 receptor alpha 1 (IL-13Ralpha1) App 20050058645 - Dunlop, Felicity Meredith ; et al. | 2005-03-17 |
| Anti-VEGF antibodies App 20030190317 - Baca, Manuel ; et al. | 2003-10-09 |
| Methods of regulating cytokine signalling App 20030191058 - Nicholson, Sandra Elaine ; et al. | 2003-10-09 |
| Method of modulating cell survival and reagents useful for same App 20020137188 - Bartlett, Perry Francis ; et al. | 2002-09-26 |
| Anti-vegf Antibodies App 20020032315 - BACA, MANUEL ; et al. | 2002-03-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 